Amgen Inc.
Unverified XFID Unique Identifier for Amgen Inc.:
XOM5380N9Y 1 Second Party Opinion
Documents (1)
| XFID | Type | Title | Year | Source | Retrieved |
|---|---|---|---|---|---|
| XF-MZVF4DY-U | Second Party Opinion | Second Party Opinion: Amgen Inc. Green Financing Framework | 2022 | www.spglobal.com | 25 Feb 2026 |
Press Coverage (20)
News and trade press mentioning this issuer, tracked in the registry.
- 2024 www.amgen.com 2024 Sustainability Highlights Report | Amgen
- 2024 XF6J9G5FPT
- 2019 www.amgen.com Amgen Response in Support of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias | Amgen
- www.amgen.com Archived Reports | Amgen
- www.amgen.com Reporting and Metrics | Amgen
- www.amgen.com Responsible Sourcing | Amgen
- www.amgen.com Environmental Sustainability | Amgen
- www.amgen.com Healthy Planet | Amgen
- www.amgen.com Health Equity | Amgen
- www.amgen.com Amgen Foundation and Community Investment | Amgen
- www.amgen.com Access to Healthcare | Amgen
- www.amgen.com Healthy Patients & Communities | Amgen
- www.amgen.com Corporate Sustainability Strategy | Amgen
- www.amgen.com Our Workforce | Amgen
- www.amgen.com Ethical Research | Amgen
- www.amgen.com Cybersecurity and Data Privacy | Amgen
- www.amgen.com Business Ethics and Compliance | Amgen
- www.amgen.com Healthy Amgen | Amgen
- www.amgen.com Responsibility | Amgen
- www.amgeniss.com ISS home page